3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Neoplasms
14
Prostatic Neoplasms
10
Hematologic Neoplasms
9
Colorectal Neoplasms
8
Lung Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
5
Squamous Cell Carcinoma of Head and Neck
4
Anatomic Stage I Breast Cancer AJCC v8
4
Triple Negative Breast Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Mouth Neoplasms
3
Melanoma
3
Malignant Solid Neoplasm
3
Leukemia, Myeloid, Acute
3
Head and Neck Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Parotid Neoplasms
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Head and Neck Carcinoma
2
Glioma
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Basal Cell
2
COVID-19
2
Interventions
pembrolizumab
3
fludarabine
3
aldesleukin
3
Cyclophosphamide
3
cabozantinib
2
Specimen Handling
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
olaparib
1
gallium 68 PSMA-11
1
enfortumab vedotin
1
darolutamide
1
Therapeutics
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Pluvicto
1
Mitomycin
1
Lutetium-177
1
Lutetium
1
Loperamide
1
Geriatric Assessment
1
Gemcitabine
1
Fulvestrant
1
Fluorouracil
1
Fecal Microbiota Transplantation
1
Exercise
1
Continuous Positive Airway Pressure
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urogenital Neoplasms
×
Standard of Care
×
90 days
×
Clear all
No trials found.